Poster presentations may not seem as prestigious as oral presentations, but they are a great opportunity to interact with other scientists in your field in a reasonably structured way. Just like ...

Presenters are kindly asked not to exceed the size of the board. Posters presented in the Sessions are asked to be set-up during the lunch break on the day of presentation. Posters must be taken down ...

Research posters are a commonly used form of dissemination of academic work. Many academic conferences will include poster presentations as part of the event, which will provide opportunities for ...

All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday in the last week of the fall and winter semesters ...

Over the past decade, only 1 out of every 3 contributed abstracts has been submitted for a poster. Despite some misconceptions, ESA does not cap the number of oral presentations or re-assign some ...

Please view posters and audio presentations below. These showcase some of the work carried out by colleagues at De Montfort University and who have worked on their Academic Innovation Projects (AIP).

The results of these projects are showcased during an annual Student Research Poster Day in April. Students and faculty members also regularly present posters at national pharmacy conferences, ...

Analyse their responses and body language to make sure they understand – because presentations are often one on one, you can ask at any time if they have questions. Also, if they don't seem interested ...

PharmaJet needle-free delivery enhances immune response and provides safety, efficacy, efficiency, and patient comfort for intradermal and intramuscular applications, outperforming traditional ...

The poster presentation will highlight recent partner study results showing immunogenicity improvement when delivered with the PharmaJet Stratis ® including: “PharmaJet Needle-free Systems ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies ...

Atea Pharmaceuticals (AVIR) announced it presented three poster presentations supporting the combination of bemnifosbuvir and ruzasvir as a potential treatment for hepatitis C virus, or HCV.